NDC 70677-0153-01 - Ibuprofen Oral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-0153
- Requested NDC
- 70677-0153-01
- Package NDCs from labels
- 70677-0153-1, 70677-0153-01
- Manufacturer
- Strategic Sourcing Services | AptaPharma Inc.
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) | Strategic Sourcing Services | AptaPharma Inc. | 2022-08-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-0153-1 | Ibuprofen Oral | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 | |
| 70677-0153-1 | Ibuprofen Oral | 1 in 1 CARTON | SUSPENSION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-0153 | IBUPROFEN ORAL (IBUPROFEN ORAL) SUSPENSION [STRATEGIC SOURCING SERVICES] | 1 | Current NDC, Legacy NDC, 2 package rows | 20220811_a3062142-db0e-4758-a762-2b2bb05670b1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-0153-1 | ML - Milliliter | 70677-0153 | b4e8be0e-e5f7-4a79-9455-79aaa2fb6e4f | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Bloop Hemorrhoid Relief Topical | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Three Nations Corp | 0b6419e3-f1c7-bdfe-e063-6294a90a5d92 | 2023-11-30 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 7152b6ce-6113-4003-bf80-aa263be69392 | 2023-11-24 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | A-S Medication Solutions | 400faee1-f662-470e-bcd6-7711dfaf9ba2 | 2023-11-24 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Childrens Ibuprofen | IBUPROFEN | Chain Drug Marketing Association Inc. | e210c707-2bae-44a5-93dc-459dd24fd960 | 2023-11-20 | Warnings | 197803 WK2XYI10QM |
| Saccharum officinale | SUCROSE | Boiron | 86d04552-b31a-0fcf-e053-2991aa0acecd | 2023-11-14 | C151H8M554 | |
| Saccharum officinale | SUCROSE | Boiron | 86d05561-6f09-6f1f-e053-2a91aa0a4b98 | 2023-11-14 | C151H8M554 | |
| Childrens Ibuprofen | IBUPROFEN | Chain Drug Marketing Association Inc. | c7e59784-a338-4922-a806-98c7505957cd | 2023-11-10 | Warnings | 197803 WK2XYI10QM |
| Concentrated ibuprofen infants | IBUPROFEN | Chain Drug Marketing Association Inc. | c9ae72d8-d205-4736-9bc4-2325cd77d36b | 2023-11-03 | Warnings | WK2XYI10QM |
| foster and thrive ibuprofen pm | DIPHENHYDRAMINE CITRATE, IBUPROFEN | Strategic Sourcing Services LLC | 8691e397-e598-4e23-a389-2dbbb8f4496a | 2023-11-01 | Warnings | WK2XYI10QM |
| foster and thrive ibuprofen | IBUPROFEN | Strategic Sourcing Services LLC | 68d67a25-e669-47c7-8410-9f304b914ff1 | 2023-10-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Geri-Care Pharmaceutical Corp | 0744c3ca-4224-4f6a-a033-880949b544fd | 2023-10-30 | Warnings | WK2XYI10QM |
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 0f17c50f-3761-4470-bf3b-63837a287b8a | 2023-10-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Ibuprofen | IBUPROFEN | TIME CAP LABORATORIES, INC. | 059cb22f-f6db-5d03-e063-6294a90a9ec1 | 2023-10-27 | Warnings | WK2XYI10QM |
| Dual Action Pain Relief | ACETAMINOPHEN, IBUPROFEN | TIME CAP LABORATORIES, INC. | 08acd3bf-ad0c-f693-e063-6394a90ad8c2 | 2023-10-27 | Warnings | WK2XYI10QM |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, PETROLATUM | FRONT PHARMACEUTICAL PLC | eb1785f4-5876-443b-b175-9b59d65d1a48 | 2023-10-26 | Warnings | PDC6A3C0OX |
| CVS Health Hemorrhoidal Cream | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | FRONT PHARMACEUTICAL PLC | cb448d78-553c-4e65-80c5-d4b31d7b3661 | 2023-10-26 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Cardinal Health 110, LLC. dba Leader | 85a51d5c-679e-1959-e053-2a91aa0a76d5 | 2023-10-25 | Warnings | PDC6A3C0OX |
| Childrens Ibuprofen | IBUPROFEN | Chain Drug Marketing Association Inc. | ba0baba6-a7f9-4e4c-88f7-c7fbecc61f25 | 2023-10-25 | Warnings | 197803 WK2XYI10QM |
| Family Wellness | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, PETROLATUM | Zhejiang Jingwei Pharmaceutical Co., Ltd. | fde9cd90-d63c-4058-b46e-511fecea36ec | 2023-10-24 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.